Insider selling at UTI signals a strategic shift? Brochick George W. recently sold 5,000 shares at $36.59—what does it mean for investors and the company’s future?
CEO Grant Jerome Alan’s recent UTI share sale shows routine portfolio rebalancing—investors note his continued long‑term stake amid rising stock and institutional buying.